Article
Model for end-stage liver disease (MELD) exception for portal hypertensive gastrointestinal bleeding.
New York Medical College, Westchester Medical Center, Valhalla, NY, USA.
Liver Transplantation (impact factor:
3.39).
12/2006;
12(12 Suppl 3):S112-3.
DOI:10.1002/lt.20969
pp.S112-3
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula.
Liver Transplantation 12/2006; 12(12 Suppl 3):S128-36. · 3.39 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
